Core Viewpoint - Ryder System, Inc. reported better-than-expected earnings for Q3 2024, leading to a 0.6% increase in share price since the earnings release on October 24, 2024 [1] Financial Performance - Quarterly earnings per share (EPS) were $3.44, exceeding the Zacks Consensus Estimate of $3.39, but down 3.9% year over year due to weaker market conditions in rental and used vehicle sales [2] - Total revenues reached $3.16 billion, falling short of the Zacks Consensus Estimate of $3.36 billion, but improved by 8.3% year over year [3] - Operating revenues of $2.59 million grew by 9% year over year, attributed to recent acquisitions [3] Segmental Results - Fleet Management Solutions generated total revenues of $1.47 billion, down 1% year over year, while operating revenues increased by 1% to $1.28 million due to higher ChoiceLease revenues [4] - Supply-Chain Solutions saw total revenues rise by 10% year over year to $1.31 billion, driven by recent acquisitions [4] - Dedicated Transportation Solutions reported total revenues of $633 million, a 41% increase year over year, with operating revenues up 49% to $486 million, also due to acquisitions [5] Liquidity & Capital Expenditures - Ryder ended Q3 with cash and cash equivalents of $162 million, slightly down from $164 million in the previous quarter, while total debt increased to $7.60 billion from $7.53 billion [6] - The company generated $629 million in net cash from operating activities, with free cash flow at $147 million and capital expenditures of $598 million [6] Outlook - For Q4 2024, Ryder expects adjusted EPS in the range of $3.32-$3.52, with the Zacks Consensus Estimate at $3.69 [7] - The updated guidance for 2024 estimates adjusted EPS between $11.90 and $12.10, with the prior view being $11.90 and $12.40 [7] - Total revenues are anticipated to increase by nearly 7%, down from a prior estimate of 8%, while operating revenues are still forecasted to rise by 8% [8]

Ryder (R) reported $3.17 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 8.3%. EPS of $3.44 for the same period compares to $3.58 a year ago.The reported revenue represents a surprise of -5.95% over the Zacks Consensus Estimate of $3.37 billion. With the consensus EPS estimate being $3.39, the EPS surprise was +1.47%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expect ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 1-4364 RYDER SYSTEM, INC. (Exact name of registrant as specified in its charter) Florida 59-0739250 (State or other jurisdiction of incorp ...

Ryder (R) came out with quarterly earnings of $3.44 per share, beating the Zacks Consensus Estimate of $3.39 per share. This compares to earnings of $3.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.47%. A quarter ago, it was expected that this truck leasing company would post earnings of $2.88 per share when it actually produced earnings of $3, delivering a surprise of 4.17%.Over the last four quarters, the company has ...

News Release Ryder Reports Third Quarter 2024 Results Delivers Solid Q3 Results; Continues to Outperform Prior Cycles Third Quarter 2024 Highlights • GAAP EPS from continuing operations of $3.25 compared to $3.44 in prior year • Comparable EPS (non-GAAP) from continuing operations of $3.44, as compared to $3.58 in prior year, reflecting weaker market conditions in rental and used vehicle sales, partially offset by higher earnings in contractual lease, supply chain, and dedicated businesses • Total revenue o ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Ryder (R) , which belongs to the Zacks Transportation - Equipment and Leasing industry, could be a great candidate to consider.This truck leasing company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 18.13%.For the most recent quarter, Ryder ...

Wall Street analysts forecast that Ryder (R) will report quarterly earnings of $3.39 per share in its upcoming release, pointing to a year-over-year decline of 5.3%. It is anticipated that revenues will amount to $3.37 billion, exhibiting an increase of 15.2% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone an upward revision of 1.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their ini ...

Ryder (R) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The earnings report, which is expected to be released on October 24, 2024, might help the stock move higher if these key numbers are better than expect ...

Core Viewpoint - Elite Pharmaceuticals has received marketing approval from the Israeli Ministry of Health for its generic version of Adderall®, which is indicated for the treatment of ADHD and Narcolepsy [2][3]. Company Overview - Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing niche generic products, including immediate-release and controlled-release solid oral dose products [4]. - The company operates a cGMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ [4]. Product Details - The approved generic Adderall® comes in strengths of 10 mg, 20 mg, and 30 mg tablets and is a central nervous system stimulant [2]. - The product will be supplied to Dexcel Pharma, the exclusive distributor for the Israeli market, under a License and Distribution Agreement [3]. Distribution Agreement - Under the agreement, Elite will manufacture and package the product, while Dexcel will handle sales, marketing, and distribution at its own expense [3]. - Dexcel will pay an agreed transfer price for the product and share profits under certain conditions [3].

Ryder System (R) has displayed an impressive performance, with its shares appreciating 20.3% over the past six months. This growth is impressive and has outperformed its industry. Additionally, Ryder's price performance compares favorably with that of other companies in the Equipment and Leasing industry like Wabtec Corporation (WAB) and Air Lease Corporation (AL) . Six-Month Price Performance Given the recent rally, the question that naturally arises is whether Ryder stock can sustain its bullish price per ...